CG Oncology, Inc. Common stock (CGON)
NASDAQ·Healthcare·Biotechnology
$65.74
-1.62%
Mkt Cap $5.90B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 27, 2026 | $450.54K | $2.30M | +410.50% | -$0.61 | -$0.51 | +16.39% | — | — |
| Q4 2025 Nov 14, 2025 | $59.36K | $1.67M | +2706.41% | -$0.56 | -$0.57 | -1.96% | — | — |
| Q3 2025 Aug 8, 2025 | $81.62K | — | — | -$0.49 | -$0.54 | -10.20% | — | — |
| Q2 2025 May 13, 2025 | $118.17K | $52.00K | -56.00% | -$0.39 | -$0.45 | -15.38% | — | — |
| Q1 2025 Mar 28, 2025 | $123.95K | $456.00K | +267.89% | -$0.41 | -$0.48 | -17.07% | — | — |
| Q3 2024 Aug 8, 2024 | — | $111.00K | — | -$0.42 | -$0.28 | +33.33% | — | — |
| Q2 2024 May 9, 2024 | — | $529.00K | — | -$0.35 | -$0.36 | -2.86% | — | — |